Daily Blueberries Shifted a Key Gut Enzyme Linked to GABA in Older Adults With Depression

If you have been wondering whether something as simple as eating more blueberries could ease a low mood, a small new pilot study offers an early signal worth paying attention to, while also making clear that the science is still very preliminary. Researchers assigned older, sedentary adults with mild depressive symptoms to eat the equivalent of roughly two cups of fresh blueberries per day for three months, then looked closely at what happened inside their guts. The headline finding is not a cure, but it is an interesting clue about how diet might nudge the gut-brain axis (the two-way communication network linking your digestive tract and your brain).

Key takeaways:

• Daily blueberry intake significantly increased the gut abundance of an enzyme involved in producing GABA, a calming neurotransmitter, in older adults with mild depression.
• Depressive symptoms trended toward greater improvement in the blueberry group, but the difference was not statistically significant compared to placebo.
• This was a pilot study of only 18 people; results are early and cannot yet support recommendations for blueberries as a depression treatment.
• The gut-brain axis remains a promising but unproven target for dietary interventions in older adult mental health.

Blueberries Boosted a Gut Enzyme Involved in GABA Production

The core finding from this pilot trial, published in The Journal of Nutrition, Health & Aging, is that three months of daily blueberry powder consumption significantly increased the gene abundance of a gut enzyme called EC 3.6.3.31 Polyamine Transporting ATPase in the blueberry group but not the placebo group. That enzyme matters because it helps transport putrescine, a compound that gut bacteria can convert into GABA (gamma-aminobutyric acid), the brain's primary inhibitory neurotransmitter and one that plays a well-known role in regulating anxiety and mood. An in vitro study cited by the authors found that incubation with blueberries directly increased GABA production, lending some biological plausibility to the signal. Broader measures of gut bacterial species composition, metabolic pathways, and fecal short-chain fatty acids (SCFAs, anti-inflammatory compounds produced when gut bacteria ferment fiber) did not shift significantly between groups.

Why This Matters for Older Adults Managing Low Mood

Depression in older adults is both common and undertreated. Between 8 and 16 percent of community-dwelling older adults have clinically relevant depressive symptoms, and subthreshold depression, a persistent low mood that does not quite meet the diagnostic bar for major depression, is two to three times more prevalent still. Research on gut microbiota and depression patterns in older adults has begun mapping how distinct microbial profiles associate with worse mental health in this population. Antidepressant medications offer limited benefit for mild or subthreshold symptoms, and psychotherapy is underutilized by older adults. That gap has researchers looking at accessible, low-risk dietary strategies. Blueberries, specifically their combination of dietary fiber and anthocyanins (the pigments that give berries their deep blue-red color and that interact directly with gut bacteria), have emerged as a candidate worth studying. Earlier research on blueberry supplementation for depression and anxiety in other populations has shown reduced symptoms, and a previous study in younger adults with major depression also reported improvements after blueberry supplementation, making this older-adult trial a logical next step.

What the Researchers Actually Did

The study enrolled sedentary adults aged 65 and older who had mild depressive symptoms, randomized them into two groups, and ran a double-blind, placebo-controlled parallel-arm trial for three months. Eighteen participants completed the study. The blueberry group consumed 48 grams per day of freeze-dried blueberry powder, equivalent to roughly two cups of fresh berries and providing about 190 calories, 28 grams of total sugars, and 11 grams of fiber. The placebo group consumed an isocaloric maltodextrin-based powder designed to look and taste similar. Both groups were asked to avoid other fiber- and anthocyanin-rich foods during the study. Gut microbiome analysis used metagenomic sequencing, which reads actual microbial DNA from stool samples, covering both species-level taxonomy and the functional gene catalog, specifically the enzyme commissions (ECs) that encode what those bacteria are capable of doing metabolically. The gut-brain axis framing here is important: the researchers were not just asking whether the berry changed which bacteria were present, but whether it changed what those bacteria were equipped to do.

What This Could Mean If You Are Managing Mood or Aging-Related Health

For anyone already thinking about gut health and mood, the GABA-pathway signal is the most clinically interesting thread here. GABA is the neurotransmitter targeted by benzodiazepines and many sedatives, and its regulation is considered relevant to both anxiety and depression. The blueberry group also showed a slight, non-significant increase in serum BDNF (brain-derived neurotrophic factor, a protein that supports neuron growth and survival and is hypothesized to be regulated by effective antidepressants), while the placebo group showed minor BDNF reductions. Across the full sample, increases in BDNF were correlated with reductions in depressive symptom scores, with a correlation coefficient of r = -0.43, though this did not reach conventional statistical significance (p = 0.08). Research on probiotics for depression and anxiety in older adults has similarly found modest mood signals via gut-targeted approaches, suggesting the broader gut-brain strategy has biological legs even if no single intervention has proven itself definitively. None of this is sufficient to recommend blueberries as a treatment for depression. But for older adults already eating a reasonably varied diet, adding two cups of berries daily carries negligible risk and may be worth discussing with a physician as part of a broader conversation about lifestyle and mood.

Significant Limitations Make These Results Preliminary

This study's constraints are substantial and the authors are candid about them. Only 18 participants completed the trial, which is far too small to detect statistically significant between-group differences in mood outcomes with confidence, and as systematic reviews of dietary gut microbiome trials have documented, results from small, heterogeneous dietary studies rarely replicate cleanly. The sample was also predominantly white, female, and highly educated, limiting how broadly the findings can be generalized. Participants had very mild depressive symptoms to begin with, which may have created a floor effect (too little room to improve). The maltodextrin placebo is not entirely inert and could have its own effects on gut bacteria. Crucially, the researchers could not measure fecal acetate, the most abundant SCFA, leaving a significant gap in the metabolite picture. And because the enzyme commission changes did not align with measurable pathway or metabolite changes, the authors acknowledge that interpreting the EC shifts remains speculative. All mental well-being outcomes improved in both groups, a pattern consistent with the well-documented "study staff interaction" effect, where simply being enrolled, monitored, and cared for in a research setting improves self-reported mood.

What Comes Next in Blueberry-Gut-Brain Research

The authors call for larger, more diverse trials with comprehensive SCFA measurement, longer durations, and tighter control of baseline group differences (the blueberry group had significantly higher baseline anxiety scores than the placebo group, which complicates the analysis). Future studies should also collect multiple stool samples per visit to capture day-to-day microbiome variability, which a single sample per visit misses. The GABA-enzyme and BDNF threads are specific enough to follow in a powered trial. Until then, this study is best understood as a carefully designed feasibility signal: it shows that blueberry consumption can shift gut microbial enzyme activity in a potentially relevant direction, and that a properly powered trial is warranted.

Common Questions

Does eating blueberries treat depression? No. This pilot study found a shift in a gut enzyme linked to GABA production, but depressive symptom improvements were not statistically different from placebo. Blueberries are not a proven depression treatment.

How much blueberry did the study use? Participants consumed 48 grams of freeze-dried blueberry powder daily, equivalent to roughly two cups of fresh blueberries, for three months.

What is GABA and why does it matter for mood? GABA is the brain's main calming neurotransmitter. Low GABA activity is associated with anxiety and depression, and many psychiatric medications work partly by enhancing GABA signaling.

Should older adults with mild depression try blueberries? Two cups of blueberries daily is a low-risk dietary addition for most people, but it should not replace evaluation and treatment by a doctor. The evidence base here is very early-stage.

References

1. Courtney L. Millar, Mohit P. Chopra, Xochitl Morgan, et al. (2026). A pilot study of daily blueberry intake modulates the gut microbiota enzyme commissions in older, sedentary adults with mild depressive symptoms. The Journal of nutrition, health and aging. https://doi.org/10.1016/j.jnha.2026.100958
2. Gut bacteria and metabolites reveal depression-linked patterns in older adults. NIH. https://pubmed.ncbi.nlm.nih.gov/38680324/
3. Katy E. Venable, D. Parker Kelley, Alec Jeansonne, et al. (2025). Effects of Blueberry Supplementation on Depression and Anxiety Symptoms in a Rural Louisiana Population. Nutrients. https://doi.org/10.3390/nu17233720
4. The gut microbiome is associated with common mental disorders in the general population. Nature. https://www.nature.com/articles/s41467-022-35422-8
5. Nihal Haque (2023). Reply to: Artificial intelligence in geriatric medicine: Potentials and pitfalls. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18567
6. Dietary interventions and the gut microbiota: a systematic literature review of 80 controlled clinical trials. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749871/